Bank of New York Mellon’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Buy |
|
|||||
|
2025
Q1 | $127K | Buy |
|
|||||
|
2024
Q4 | $168K | Buy |
|
|||||
|
2024
Q3 | $157K | Sell |
|
|||||
|
2024
Q2 | $218K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $41.5K | Sell |
|
|||||
|
2022
Q4 | $106K | Sell |
|
|||||
|
2022
Q3 | $102K | Hold |
|
|||||
|
2022
Q2 | $360K | Sell |
|
|||||
|
2022
Q1 | $143K | Buy |
|
|||||
|
2021
Q4 | $69K | Hold |
|
|||||
|
2021
Q3 | $309K | Hold |
|
|||||
|
2021
Q2 | $326K | Sell |
|
|||||
|
2021
Q1 | $688K | Buy |
|
|||||
|
2020
Q4 | $506K | Buy |
|
|||||
|
2020
Q3 | $337K | Buy |
|
|||||
|
2020
Q2 | $419K | Buy |
|
|||||
|
2020
Q1 | $113K | Sell |
|
|||||
|
2019
Q4 | $178K | Hold |
|
|||||
|
2019
Q3 | $128K | Hold |
|
|||||
|
2019
Q2 | $192K | Sell |
|
|||||
|
2019
Q1 | $472K | Sell |
|
|||||
|
2018
Q4 | $478K | Sell |
|
|||||
|
2018
Q3 | $794K | Buy |
|
|||||
|
2018
Q2 | $675K | Buy |
|
|||||
|
2018
Q1 | $799K | Buy |
|
|||||
|
2017
Q4 | $300K | Sell |
|
|||||
|
2017
Q3 | $111K | Sell |
|
|||||
|
2017
Q2 | $107K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $11K | Sell |
|
|||||
|
2016
Q3 | $21K | Sell |
|
|||||
|
2016
Q2 | $32K | Buy |
|
|||||
|
2016
Q1 | $31K | Hold |
|
|||||
|
2015
Q4 | $58K | Sell |
|
|||||
|
2015
Q3 | $86K | Buy |
|
|||||
|
2015
Q2 | $362K | Buy |
|
|||||
|
2015
Q1 | $369K | Hold |
|
|||||
|
2014
Q4 | $327K | Hold |
|
|||||
|
2014
Q3 | $314K | Hold |
|
|||||
|
2014
Q2 | $560K | Sell |
|
|||||
|
2014
Q1 | $1.12M | Sell |
|
|||||
|
2013
Q4 | $988K | Buy |
|
|||||
|
2013
Q3 | $1.14M | Buy |
|
|||||
|
2013
Q2 | $675K | Buy |
|